about
The genetic polymorphisms of HER-2 and the risk of lung cancer in a Korean populationShrunken methodology to genome-wide SNPs selection and construction of SNPs networksGenome-wide association studies in cancer--current and future directionsThe use of microarray technologies in clinical oncologyA novel multiplex tetra-primer ARMS-PCR for the simultaneous genotyping of six single nucleotide polymorphisms associated with female cancers.Information-theoretic identification of predictive SNPs and supervised visualization of genome-wide association studies.Nano-enabled bioanalytical approaches to ultrasensitive detection of low abundance single nucleotide polymorphisms.A Single Nucleotide Polymorphism in Catalase Is Strongly Associated with Ovarian Cancer SurvivalFunctional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma.Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.Polymorphisms in the p63 and p73 genes are associated with ovarian cancer risk and clinicopathological variablesThe HapMap Resource is Providing New Insights into Ourselves and its Application to Pharmacogenomics.Approaches to uncovering cancer diagnostic and prognostic molecular signaturesA polymorphism at the 3'-UTR region of the aromatase gene is associated with the efficacy of the aromatase inhibitor, anastrozole, in metastatic breast carcinoma.Systems biology: new approaches to old environmental health problemsGenetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.Opinion on moderate/low cancer genetic risk markers in medical practice including comment on the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tuPolymorphism at P21 codon 31 and dinucleotide polymorphism of P73 gene and susceptibility to bladder cancer in individuals from North IndiaRelationship between EGF, TGFA, and EGFR Gene Polymorphisms and Traditional Chinese Medicine ZHENG in Gastric Cancer.Single-nucleotide polymorphism discovery by targeted DNA photocleavage.Current status of genome-wide association studies in cancer.Restoring TRAIL mediated signaling in ovarian cancer cells.Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.A single quantum dot-based biosensor for DNA point mutation assay.Gene polymorphisms and oral cancer risk in tobacco habitués.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.Detection of HER2 polymorphism and expression using circulating DNA and RNA as a tool in lung adenocarcinoma patients: a case control studyRs1008805 polymorphism of CYP19A1 gene is associated with the efficacy of hormone therapy in stage I-II and operable stage III breast cancer.Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population.Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma.The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer.[Polymorphism on codon 98 of the galectin-3 gene is not associated to benign and malignant thyroid tumors].SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
P2860
Q33389608-A535836B-0C14-42C6-8938-586D6A9B48EFQ33692317-768AE42C-1DEB-446C-9984-C2CF8FD6A993Q33814805-5621E00F-1CB0-44F8-B14E-E64728F4AF00Q34496896-841025BC-9B08-46FB-9059-50429A545C9BQ34685625-E69E4FDF-7582-4EB1-B62E-96D6A2BFC089Q35013105-82817899-4438-48F7-9BCE-67292F9F7995Q35686571-F851086C-3576-4D47-AB77-2B1CC5737FF2Q35753523-0565F90A-4A3A-4EF5-83B4-77EF4D26FEFFQ36069534-C3D9FF6D-C4A3-4968-A16B-F076B4324A9DQ36077746-36C7612B-50B6-4C61-A736-959A6D4AAC16Q36523707-78AAFB80-3CBD-429A-8D80-96679462D993Q36528253-250121EE-891C-485A-AB0E-97B7B74CCC69Q36997737-41EF030B-720D-4BFE-BC1D-7152B4911862Q37225249-138222F7-83C0-46B9-95D8-089E8041BD72Q37271903-3DA747AE-8EA7-4716-9CD7-177C6A2E9EF6Q37295196-913D41E9-89A9-40DA-B547-B7F5C495EF8CQ37326661-6B7650B9-6679-4990-9B13-3160CFA20001Q37345380-21220983-C9B2-4D8D-A1DE-6AFDC02AA98BQ37422984-877F27F2-83D8-4DE4-A862-E2635EE4DB60Q37557403-10D03509-34EB-4434-A101-9AE0C727979FQ37890286-33E07E1C-B446-40CD-9B60-13777238E8EBQ38230205-A39732F4-8068-47F6-B11B-EEFC12E3B78EQ38440406-639BE493-883F-4F04-9C4C-630B8E1706D3Q38847929-B187D3AD-B7DF-464D-B060-E3B8614C1C47Q41091396-0C4A3A2A-F87F-48BA-A473-425E8D8542C8Q41603225-13AF86C4-E9B6-41BA-B5DE-538CC38C073CQ42106918-B4A33D86-DE85-46C0-BD2D-E7A5D964A771Q44502008-2180412C-D707-4B07-B86C-B2D87229CAA3Q44770564-A00EE14C-A24C-42BD-8888-D7A1B3056CCDQ47101376-5FAA0DD9-502F-4915-95F6-7397E64D5A87Q51001468-6066CBBC-0324-4A7A-B9BE-830C8A0FE57EQ54562505-7366A637-BFCD-4DC3-A304-4630BEB46DA6Q55497899-90A4BA52-9BC9-4AE3-B516-D67A699BC26B
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
SNPs in cancer research and treatment.
@ast
SNPs in cancer research and treatment.
@en
type
label
SNPs in cancer research and treatment.
@ast
SNPs in cancer research and treatment.
@en
prefLabel
SNPs in cancer research and treatment.
@ast
SNPs in cancer research and treatment.
@en
P2860
P356
P1476
SNPs in cancer research and treatment.
@en
P2093
H C Erichsen
S J Chanock
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601574
P407
P577
2004-02-01T00:00:00Z
2004-02-23T00:00:00Z